ID   ARBK1_HUMAN             Reviewed;         689 AA.
AC   P25098; B0ZBE1; Q13837; Q6GTT3;
DT   01-MAY-1992, integrated into UniProtKB/Swiss-Prot.
DT   20-FEB-2007, sequence version 2.
DT   05-OCT-2010, entry version 125.
DE   RecName: Full=Beta-adrenergic receptor kinase 1;
DE            Short=Beta-ARK-1;
DE            EC=2.7.11.15;
DE   AltName: Full=G-protein coupled receptor kinase 2;
GN   Name=ADRBK1; Synonyms=BARK, BARK1, GRK2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   MEDLINE=91243858; PubMed=2037065; DOI=10.1016/0014-5793(91)80568-N;
RA   Benovic J.L., Stone W.C., Huebner K., Croce C., Caron M.G.,
RA   Lefkowitz R.J.;
RT   "cDNA cloning and chromosomal localization of the human beta-
RT   adrenergic receptor kinase.";
RL   FEBS Lett. 283:122-126(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Blood;
RX   MEDLINE=92202245; PubMed=1339451;
RA   Chuang T.T., Sallese M., Ambrosini G., Parruti G., de Blasi A.;
RT   "High expression of beta-adrenergic receptor kinase in human
RT   peripheral blood leukocytes. Isoproterenol and platelet activating
RT   factor can induce kinase translocation.";
RL   J. Biol. Chem. 267:6886-6892(1992).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   MEDLINE=94253044; PubMed=8195124;
RA   Penn R.B., Benovic J.L.;
RT   "Structure of the human gene encoding the beta-adrenergic receptor
RT   kinase.";
RL   J. Biol. Chem. 269:14924-14930(1994).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   NHLBI resequencing and genotyping service (RS&G);
RL   Submitted (DEC-2007) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=PNS, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   INTERACTION WITH ARRB1.
RX   PubMed=9501202; DOI=10.1073/pnas.95.6.2985;
RA   Aragay A.M., Mellado M., Frade J.M., Martin A.M., Jimenez-Sainz M.C.,
RA   Martinez-A C., Mayor F. Jr.;
RT   "Monocyte chemoattractant protein-1-induced CCR2B receptor
RT   desensitization mediated by the G protein-coupled receptor kinase 2.";
RL   Proc. Natl. Acad. Sci. U.S.A. 95:2985-2990(1998).
RN   [7]
RP   INTERACTION WITH CCR5, AND TISSUE SPECIFICITY.
RX   PubMed=10085131; DOI=10.1074/jbc.274.13.8875;
RA   Oppermann M., Mack M., Proudfoot A.E., Olbrich H.;
RT   "Differential effects of CC chemokines on CC chemokine receptor 5
RT   (CCR5) phosphorylation and identification of phosphorylation sites on
RT   the CCR5 carboxyl terminus.";
RL   J. Biol. Chem. 274:8875-8885(1999).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-670, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Platelet;
RX   PubMed=18088087; DOI=10.1021/pr0704130;
RA   Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,
RA   Schuetz C., Walter U., Gambaryan S., Sickmann A.;
RT   "Phosphoproteome of resting human platelets.";
RL   J. Proteome Res. 7:526-534(2008).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RA   Colinge J., Superti-Furga G., Bennett K.L.;
RL   Submitted (OCT-2008) to UniProtKB.
RN   [10]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND MASS SPECTROMETRY.
RC   TISSUE=Embryonic kidney;
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-350 AND THR-353, AND
RP   MASS SPECTROMETRY.
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [12]
RP   FUNCTION, AND INTERACTION WITH LPAR1; LPAR2 AND RALA.
RX   PubMed=19306925; DOI=10.1016/j.cellsig.2009.03.011;
RA   Aziziyeh A.I., Li T.T., Pape C., Pampillo M., Chidiac P.,
RA   Possmayer F., Babwah A.V., Bhattacharya M.;
RT   "Dual regulation of lysophosphatidic acid (LPA1) receptor signalling
RT   by Ral and GRK.";
RL   Cell. Signal. 21:1207-1217(2009).
RN   [13]
RP   STRUCTURE BY NMR OF 552-670.
RX   MEDLINE=98112832; PubMed=9446593; DOI=10.1074/jbc.273.5.2835;
RA   Fushman D., Najmabadi-Haske T., Cahill S., Zheng J., Levine H. III,
RA   Cowburn D.;
RT   "The solution structure and dynamics of the pleckstrin homology domain
RT   of G protein-coupled receptor kinase 2 (beta-adrenergic receptor
RT   kinase 1). A binding partner of Gbetagamma subunits.";
RL   J. Biol. Chem. 273:2835-2843(1998).
RN   [14]
RP   VARIANTS [LARGE SCALE ANALYSIS] THR-184 AND GLN-578.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Specifically phosphorylates the agonist-occupied form of
CC       the beta-adrenergic and closely related receptors, probably
CC       inducing a desensitization of them. Key regulator of LPAR1
CC       signaling. Competes with RALA for binding to LPAR1 thus affecting
CC       the signaling properties of the receptor. Desensitizes LPAR1 and
CC       LPAR2 in a phosphorylation-independent manner.
CC   -!- CATALYTIC ACTIVITY: ATP + [beta-adrenergic receptor] = ADP +
CC       [beta-adrenergic receptor] phosphate.
CC   -!- SUBUNIT: Interacts with GIT1 (By similarity). Interacts with, and
CC       phosphorylates chemokine-stimulated CCR5. Interacts with ARRB1.
CC       Interacts with LPAR1 and LPAR2. Interacts with RALA in response to
CC       LPAR1 activation. ADRBK1 and RALA mutually inhibit each other's
CC       binding to LPAR1.
CC   -!- TISSUE SPECIFICITY: Expressed in peripheral blood leukocytes.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. AGC Ser/Thr
CC       protein kinase family. GPRK subfamily.
CC   -!- SIMILARITY: Contains 1 AGC-kinase C-terminal domain.
CC   -!- SIMILARITY: Contains 1 PH domain.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- SIMILARITY: Contains 1 RGS domain.
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Beta adrenergic receptor kinase
CC       entry;
CC       URL="http://en.wikipedia.org/wiki/Beta_Adrenergic_Receptor_Kinase";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X61157; CAA43470.1; -; mRNA.
DR   EMBL; M80776; AAA58391.1; -; mRNA.
DR   EMBL; U08438; AAB60689.1; -; Genomic_DNA.
DR   EMBL; U08435; AAB60689.1; JOINED; Genomic_DNA.
DR   EMBL; U08436; AAB60689.1; JOINED; Genomic_DNA.
DR   EMBL; U08437; AAB60689.1; JOINED; Genomic_DNA.
DR   EMBL; EU326303; ACA05909.1; -; Genomic_DNA.
DR   EMBL; BC037963; AAH37963.1; -; mRNA.
DR   EMBL; BC090863; AAH90863.1; -; mRNA.
DR   IPI; IPI00012497; -.
DR   PIR; A53791; A53791.
DR   RefSeq; NP_001610.2; -.
DR   UniGene; Hs.83636; -.
DR   PDB; 1BAK; NMR; -; A=556-670.
DR   PDB; 3CIK; X-ray; 2.75 A; A=1-689.
DR   PDB; 3KRW; X-ray; 2.90 A; A=2-689.
DR   PDB; 3KRX; X-ray; 3.10 A; A=2-689.
DR   PDBsum; 1BAK; -.
DR   PDBsum; 3CIK; -.
DR   PDBsum; 3KRW; -.
DR   PDBsum; 3KRX; -.
DR   ProteinModelPortal; P25098; -.
DR   DIP; DIP-42429N; -.
DR   MINT; MINT-1214643; -.
DR   STRING; P25098; -.
DR   PhosphoSite; P25098; -.
DR   PRIDE; P25098; -.
DR   Ensembl; ENST00000308595; ENSP00000312262; ENSG00000173020.
DR   GeneID; 156; -.
DR   KEGG; hsa:156; -.
DR   UCSC; uc009yrn.1; human.
DR   CTD; 156; -.
DR   GeneCards; GC11P067033; -.
DR   H-InvDB; HIX0026185; -.
DR   HGNC; HGNC:289; ADRBK1.
DR   MIM; 109635; gene.
DR   PharmGKB; PA40; -.
DR   eggNOG; prNOG18800; -.
DR   HOGENOM; HBG443643; -.
DR   HOVERGEN; HBG050559; -.
DR   InParanoid; P25098; -.
DR   OMA; IQRGSAN; -.
DR   OrthoDB; EOG9VHNSD; -.
DR   PhylomeDB; P25098; -.
DR   BRENDA; 2.7.11.15; 247.
DR   Pathway_Interaction_DB; hdac_classii_pathway; Signaling events mediated by HDAC Class II.
DR   Pathway_Interaction_DB; hedgehog_2pathway; Signaling events mediated by the Hedgehog family.
DR   Pathway_Interaction_DB; txa2pathway; Thromboxane A2 receptor signaling.
DR   Reactome; REACT_11061; Signalling by NGF.
DR   Reactome; REACT_14797; Signaling by GPCR.
DR   Reactome; REACT_15295; Opioid Signalling.
DR   DrugBank; DB00171; Adenosine triphosphate.
DR   NextBio; 621; -.
DR   ArrayExpress; P25098; -.
DR   Bgee; P25098; -.
DR   CleanEx; HS_ADRBK1; -.
DR   Genevestigator; P25098; -.
DR   GermOnline; ENSG00000173020; Homo sapiens.
DR   GO; GO:0005829; C:cytosol; EXP:Reactome.
DR   GO; GO:0005625; C:soluble fraction; TAS:ProtInc.
DR   GO; GO:0031694; F:alpha-2A adrenergic receptor binding; ISS:BHF-UCL.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0047696; F:beta-adrenergic receptor kinase activity; IEA:EC.
DR   GO; GO:0031755; F:Edg-2 lysophosphatidic acid receptor binding; IDA:UniProtKB.
DR   GO; GO:0004703; F:G-protein coupled receptor kinase activity; ISS:BHF-UCL.
DR   GO; GO:0004871; F:signal transducer activity; IEA:InterPro.
DR   GO; GO:0060048; P:cardiac muscle contraction; IMP:BHF-UCL.
DR   GO; GO:0002029; P:desensitization of G-protein coupled recept...; ISS:BHF-UCL.
DR   GO; GO:0007213; P:muscarinic acetylcholine receptor signaling...; ISS:BHF-UCL.
DR   GO; GO:0045988; P:negative regulation of striated muscle cont...; IMP:BHF-UCL.
DR   GO; GO:0003108; P:negative regulation of the force of heart c...; IMP:BHF-UCL.
DR   GO; GO:0018105; P:peptidyl-serine phosphorylation; ISS:BHF-UCL.
DR   GO; GO:0033605; P:positive regulation of catecholamine secretion; ISS:BHF-UCL.
DR   GO; GO:0007217; P:tachykinin receptor signaling pathway; IDA:BHF-UCL.
DR   InterPro; IPR000961; AGC-kinase_C.
DR   InterPro; IPR015743; B-adrenergic_rcpt_kinase.
DR   InterPro; IPR000239; GPCR_kinase.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR011993; PH_type.
DR   InterPro; IPR001849; Pleckstrin_homology.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR000342; Regulat_G_prot_signal.
DR   InterPro; IPR016137; Regulat_G_prot_signal_superfam.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   InterPro; IPR008271; Ser/Thr_prot_kinase_AS.
DR   InterPro; IPR002290; Ser/Thr_prot_kinase_dom.
DR   Gene3D; G3DSA:2.30.29.30; PH_type; 1.
DR   PANTHER; PTHR22985:SF5; BARK; 1.
DR   Pfam; PF00169; PH; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   Pfam; PF00615; RGS; 1.
DR   PRINTS; PR00717; GPCRKINASE.
DR   SMART; SM00233; PH; 1.
DR   SMART; SM00315; RGS; 1.
DR   SMART; SM00133; S_TK_X; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   SUPFAM; SSF48097; Regulat_G_prot_signal_superfam; 1.
DR   PROSITE; PS51285; AGC_KINASE_CTER; 1.
DR   PROSITE; PS50003; PH_DOMAIN; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
DR   PROSITE; PS50132; RGS; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; ATP-binding; Complete proteome; Kinase;
KW   Nucleotide-binding; Phosphoprotein; Polymorphism;
KW   Serine/threonine-protein kinase; Transferase.
FT   INIT_MET      1      1       Removed.
FT   CHAIN         2    689       Beta-adrenergic receptor kinase 1.
FT                                /FTId=PRO_0000085627.
FT   DOMAIN       54    175       RGS.
FT   DOMAIN      191    453       Protein kinase.
FT   DOMAIN      454    521       AGC-kinase C-terminal.
FT   DOMAIN      558    652       PH.
FT   NP_BIND     197    205       ATP (By similarity).
FT   REGION        2    190       N-terminal.
FT   ACT_SITE    317    317       Proton acceptor (By similarity).
FT   BINDING     220    220       ATP (By similarity).
FT   MOD_RES       2      2       N-acetylalanine.
FT   MOD_RES     350    350       Phosphoserine.
FT   MOD_RES     353    353       Phosphothreonine.
FT   MOD_RES     670    670       Phosphoserine.
FT   VARIANT     184    184       I -> T (in dbSNP:rs55696045).
FT                                /FTId=VAR_040378.
FT   VARIANT     578    578       R -> Q (in a colorectal adenocarcinoma
FT                                sample; somatic mutation).
FT                                /FTId=VAR_040379.
FT   CONFLICT    168    185       SDKFTRFCQWKNVELNIH -> RISSHGFASGRMWSSTST
FT                                (in Ref. 3; AAB60689).
FT   CONFLICT    211    211       A -> R (in Ref. 1; CAA43470 and 3;
FT                                AAB60689).
FT   CONFLICT    422    422       R -> H (in Ref. 1; CAA43470 and 3;
FT                                AAB60689).
FT   CONFLICT    465    465       K -> R (in Ref. 1; CAA43470).
FT   STRAND      561    568
FT   STRAND      578    583
FT   STRAND      585    591
FT   STRAND      600    604
FT   STRAND      606    612
FT   STRAND      619    624
FT   STRAND      629    633
FT   HELIX       637    658
SQ   SEQUENCE   689 AA;  79574 MW;  4DB68F62841AFA7D CRC64;
     MADLEAVLAD VSYLMAMEKS KATPAARASK KILLPEPSIR SVMQKYLEDR GEVTFEKIFS
     QKLGYLLFRD FCLNHLEEAR PLVEFYEEIK KYEKLETEEE RVARSREIFD SYIMKELLAC
     SHPFSKSATE HVQGHLGKKQ VPPDLFQPYI EEICQNLRGD VFQKFIESDK FTRFCQWKNV
     ELNIHLTMND FSVHRIIGRG GFGEVYGCRK ADTGKMYAMK CLDKKRIKMK QGETLALNER
     IMLSLVSTGD CPFIVCMSYA FHTPDKLSFI LDLMNGGDLH YHLSQHGVFS EADMRFYAAE
     IILGLEHMHN RFVVYRDLKP ANILLDEHGH VRISDLGLAC DFSKKKPHAS VGTHGYMAPE
     VLQKGVAYDS SADWFSLGCM LFKLLRGHSP FRQHKTKDKH EIDRMTLTMA VELPDSFSPE
     LRSLLEGLLQ RDVNRRLGCL GRGAQEVKES PFFRSLDWQM VFLQKYPPPL IPPRGEVNAA
     DAFDIGSFDE EDTKGIKLLD SDQELYRNFP LTISERWQQE VAETVFDTIN AETDRLEARK
     KAKNKQLGHE EDYALGKDCI MHGYMSKMGN PFLTQWQRRY FYLFPNRLEW RGEGEAPQSL
     LTMEEIQSVE ETQIKERKCL LLKIRGGKQF ILQCDSDPEL VQWKKELRDA YREAQQLVQR
     VPKMKNKPRS PVVELSKVPL VQRGSANGL
//
